(Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | |
---|---|---|---|---|---|---|
Turnover | --2.13B | -20.16%3.77B | 22.94%4.72B | 84.54%3.84B | 14.31%2.08B | --1.82B |
Operating income | 2.13B | -20.16%3.77B | 22.94%4.72B | 84.54%3.84B | 14.31%2.08B | 1.82B |
Cost of sales | ---1.94B | 18.23%-3.23B | -23.29%-3.96B | -75.22%-3.21B | -7.23%-1.83B | ---1.71B |
Operating expenses | -1.94B | 18.23%-3.23B | -23.29%-3.96B | -75.22%-3.21B | -7.23%-1.83B | -1.71B |
Gross profit | 184.57M | -30.10%536.5M | 21.17%767.53M | 152.62%633.42M | 120.87%250.74M | 113.52M |
Selling expenses | ---13.52M | 51.22%-30.11M | 17.46%-61.72M | -164.16%-74.77M | 20.23%-28.3M | ---35.48M |
Administrative expenses | ---63.07M | 11.63%-93.4M | -66.16%-105.69M | -1.29%-63.61M | 13.84%-62.8M | ---72.89M |
Research and development expenses | ---16.79M | 0.34%-30.93M | 20.12%-31.04M | -58.49%-38.85M | -4.41%-24.52M | ---23.48M |
Impairment and provision | ---580K | 57.10%2.6M | 114.80%1.66M | -478.50%-11.18M | 140.17%2.95M | ---7.35M |
-Other impairment is provision | ---580K | 57.10%2.6M | 114.80%1.66M | -478.50%-11.18M | 140.17%2.95M | ---7.35M |
Special items of operating profit | --15.59M | 17.68%-25.48M | -517.93%-30.95M | -94.69%7.41M | 72.82%139.36M | --80.64M |
Operating profit | 106.2M | -33.46%359.19M | 19.31%539.8M | 63.07%452.42M | 404.81%277.44M | 54.96M |
Financing cost | ---10.81M | -11.02%-19.6M | -82.70%-17.65M | 7.74%-9.66M | 34.33%-10.47M | ---15.94M |
Share of profit from joint venture company | ---3.47M | -153.18%-5.99M | -60.17%11.27M | 1,487.98%28.29M | 82.34%-2.04M | ---11.54M |
Adjustment items of earning before tax | ---- | ---- | ---- | ---- | ---- | ---2.82M |
Earning before tax | 91.92M | -37.46%333.6M | 13.24%533.41M | 77.80%471.04M | 974.36%264.93M | 24.66M |
Tax | ---16.58M | 48.70%-57.41M | -50.27%-111.9M | -27.50%-74.46M | -1,307.13%-58.4M | --4.84M |
After-tax profit from continuing operations | 75.34M | -34.48%276.19M | 6.29%421.51M | 92.03%396.58M | 600.16%206.53M | 29.5M |
Earning after tax | 75.34M | -34.48%276.19M | 6.29%421.51M | 92.03%396.58M | 600.16%206.53M | 29.5M |
Minority profit | ---5.35M | 44.38%23.72M | 6,659.26%16.43M | -94.26%243K | 161.66%4.23M | --1.62M |
Profit attributable to shareholders | 80.69M | -37.67%252.48M | 2.21%405.09M | 95.92%396.34M | 625.59%202.29M | 27.88M |
Basic earnings per share | 0.089 | -38.33%0.37 | 1.69%0.6 | 96.67%0.59 | 650.00%0.3 | 0.04 |
Diluted earnings per share | 0.089 | 0.37 | ||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | Deloitte Guan Huang Chen Fang Certified Public Accountants | Deloitte Guan Huang Chen Fang Certified Public Accountants | Deloitte Guan Huang Chen Fang Certified Public Accountants | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data